Half-dose vs one-third-dose photodynamic therapy for chronic central serous chorioretinopathy

R. Uetani, Y. Ito, K. Oiwa, K. Ishikawa, H. Terasaki

Research output: Contribution to journalArticlepeer-review

48 Citations (Scopus)

Abstract

Purpose: To prospectively compare the effects of half-dose verteporfin (3 mg/m2) photodynamic therapy (1/2 PDT) with those of one-third-dose verteporfin (2 mg/m2) PDT (1/3 PDT) for chronic central serous chorioretinopathy (CSC). Methods: Sixteen eyes of 16 consecutive patients with chronic CSC were enrolled and followed up for a 3-month study period. The first 10 patients received 1/2 PDT and the next 6 patients received 1/3 PDT. The resolution rate of subretinal fluid (SRF) was compared between the two groups. The changes in the choroidal thickness inside and outside the PDT-applied area in both groups were also evaluated. Results: SRF disappeared in all eyes (100%) in the 1/2 PDT group and in two eyes (33%) in the 1/3 PDT group. In the 1/2 PDT group, choroidal thickness inside and outside the PDT-applied area reduced significantly from the baseline (inside, from 387±24 to 325±25 μm; outside, from 292±25 to 249±19 μm; both P=0.005). In the 1/3 PDT group, choroidal thickness decreased in two eyes where SRF disappeared (inside, 87.2 and 90.9% of the baseline; outside, 91.4 and 92.6% of the baseline), but did not change in the other four eyes where SRF remained (inside, 104.1, 100.0, 105.1, and 100.5% of the baseline; outside, 98.9, 103.0, 100.0, and 99.0% of the baseline). Conclusions: 1/2 PDT is more effective than 1/3 PDT in the resolution of SRF for chronic CSC. Decrease in the choroidal thickness after PDT may be related to the resolution of SRF in chronic CSC.

Original languageEnglish
Pages (from-to)640-649
Number of pages10
JournalTransactions of the Ophthalmological Societies of the United Kingdom
Volume26
Issue number5
DOIs
Publication statusPublished - 05-2012
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Ophthalmology
  • Sensory Systems

Fingerprint

Dive into the research topics of 'Half-dose vs one-third-dose photodynamic therapy for chronic central serous chorioretinopathy'. Together they form a unique fingerprint.

Cite this